Wednesday, June 10, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “GANYMED PHARMACEUTICALS GMBH [DE]”

3 pharma patents match "GANYMED PHARMACEUTICALS GMBH [DE]" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 3 pharmaceutical patents matching "GANYMED PHARMACEUTICALS GMBH [DE]" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3 results for “GANYMED PHARMACEUTICALS GMBH [DE]” · 30,257 patents in full index Clear search

  1. US 2019076525

    THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER

    GANYMED PHARMACEUTICALS GMBH [DE] · Granted Mar 14, 2019 · Expires Mar 9, 2039

    granted

  2. EP 3421496

    ANTIKÖRPER ZUR BEHANDLUNG VON CLAUDIN-6-EXPRIMIERENDEN KREBS

    GANYMED PHARMACEUTICALS GMBH [DE] · Granted Jan 2, 2019 · Expires Dec 28, 2038

    granted

  3. EP 3283521

    ARZNEIMITTELKONJUGATE MIT ANTIKÖRPERN GEGEN MIT CLAUDIN 18.2

    GANYMED PHARMACEUTICALS GMBH [DE] · Granted Feb 21, 2018 · Expires Feb 16, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.